Singapore grants interim authorisation for Novavax COVID-19 vaccine

The Health Sciences Authority (HSA) has granted an interim authorisation under the Pandemic Special Access Route (PSAR) ...

February 18, 2022 | Friday | News
Korea to run training programme on vaccines and biologics development

The International Vaccine Institute (IVI) has been designated by the Ministry of Health and Welfare (MOHW), Republic of ...

February 17, 2022 | Thursday | News
Australia provisionally approves Moderna's COVID-19 vaccine for 6-11 years old

The Therapeutic Goods Administration (TGA) in Australia has provisionally approved the Moderna COVID-19 vaccine, SPIKEVA...

February 17, 2022 | Thursday | News
China expands collaboration to develop COVID-19 multi-variant vaccine

Norway-based CEPI, the Coalition for Epidemic Preparedness Innovations, has announced that it will expand its collaborat...

February 10, 2022 | Thursday | News
Hong Kong suggests mRNA vaccinations to tackle COVID-19 variants

Researchers at AIDS Institute, Department of Microbiology, LKS Faculty of Medicine of The University of Hong Kong (HKUMe...

February 9, 2022 | Wednesday | News
China reports better antibody production with intradermal vaccination than intramuscular

Intradermal COVID-19 vaccination studies are emerging in a global effort to multiply available doses by harnessing skin ...

February 8, 2022 | Tuesday | News
Russia's Sputnik Light vaccine receives authorisation in India

The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) has announced that the Russian one-shot ...

February 7, 2022 | Monday | News
“Chinese and Russian vaccines have been disappointing relative to their overall effectiveness”

What are your views on the ongoing threat being imposed by the COVID-19 variants across the globe? How can those be best...

February 6, 2022 | Sunday | Opinion
CEPI lays focus on developing heat-stable vaccine technology

Norway-based Coalition for Epidemic Preparedness Innovations (CEPI) has launched a new 'Call for Proposals' to...

February 4, 2022 | Friday | News
New Zealand gives provisional nod to first protein-based COVID-19 vaccine

US-based Novavax, Inc. has announced that New Zealand's Medsafe has granted provisional approval of NVX-CoV237...

February 4, 2022 | Friday | News
Korean firm EuBiologics receives approval for Ph III trial of COVID-19 vaccine

EuBiologics, a South Korean biotech company, has announced that EuCorVac-19, a COVID-19 vaccine candidate obtained appro...

February 4, 2022 | Friday | News
How IP Nitty-gritties Hinder Universal Immunisation?

The coronavirus crisis which has enraged the world has also opened up debates around IP and public health.  The gen...

February 4, 2022 | Friday | Analysis
Japan grants patent to Anixa Biosciences for ovarian cancer vaccine

US-based Anixa Biosciences, Inc. has announced that the Japanese Patent Office has issued a Decision to Grant ...

February 1, 2022 | Tuesday | News
CEPI partners with BioNet to expand variant-proof vaccine programme

CEPI, the Coalition for Epidemic Preparedness Innovations, has announced the latest award under its $200 million pr...

February 1, 2022 | Tuesday | News
Daiichi Sankyo starts trial for mRNA vaccine as booster dose in Japan

Daiichi Sankyo has initiated a trial in Japan to investigate a booster dose of DS-5670, an mRNA vaccine against COVID-19...

January 31, 2022 | Monday | News
Australia approves Pfizer booster for 16–17 year olds

The Therapeutic Goods Administration (TGA) in Australia has approved the Pfizer COVID-19 booster dose for young people a...

January 28, 2022 | Friday | News
National Vaccine Institute of Thailand strengthens partnership with International Vaccine Institute

The International Vaccine Institute (IVI) in South Korea and the National Vaccine Institute (NVI) of Thailand have signe...

January 24, 2022 | Monday | News
Australia grants provisional registration for Novavax COVID-19 vaccine

Novavax, Inc. has announced that Australia's Therapeutic Goods Administration (TGA) has granted approval for p...

January 20, 2022 | Thursday | News